{"title":"Pharma funding of patient organisations.","authors":"","doi":"10.1136/dtb.2024.000060","DOIUrl":null,"url":null,"abstract":"<p><p><b>Overview of:</b> Gentilini A, Parvanova I. Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence. <i>BMJ Open.</i> 2023;13:e071138.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"163"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Therapeutics Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/dtb.2024.000060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Overview of: Gentilini A, Parvanova I. Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence. BMJ Open. 2023;13:e071138.